These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 18243013)
1. Implications of applied research for prognosis and therapy of breast cancer. Barginear MF; Bradley T; Shapira I; Budman DR Crit Rev Oncol Hematol; 2008 Mar; 65(3):223-34. PubMed ID: 18243013 [TBL] [Abstract][Full Text] [Related]
2. New molecular classifications of breast cancer. Cianfrocca M; Gradishar W CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Shi M; Guo N Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434 [TBL] [Abstract][Full Text] [Related]
4. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
5. Genomics in breast cancer-therapeutic implications. Lønning PE; Sørlie T; Børresen-Dale AL Nat Clin Pract Oncol; 2005 Jan; 2(1):26-33. PubMed ID: 16264853 [TBL] [Abstract][Full Text] [Related]
6. [The use of breast cancer subtype classification to predict local and distant recurrence. A review]. Belkacémi Y; Penault-Llorca F; Gligorov J; Azria D Cancer Radiother; 2008 Nov; 12(6-7):577-83. PubMed ID: 18824383 [TBL] [Abstract][Full Text] [Related]
7. A six-gene signature predicting breast cancer lung metastasis. Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer. Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688 [TBL] [Abstract][Full Text] [Related]
9. High-throughput techniques in breast cancer: a clinical perspective. Espinosa E; Redondo A; Vara JA; Zamora P; Casado E; Cejas P; Barón MG Eur J Cancer; 2006 Mar; 42(5):598-607. PubMed ID: 16431104 [TBL] [Abstract][Full Text] [Related]
10. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Ross JS Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609 [TBL] [Abstract][Full Text] [Related]
11. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype. Voduc D; Nielsen TO; Cheang MC; Foulkes WD Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730 [TBL] [Abstract][Full Text] [Related]
12. Proteomics, morphoproteomics, saliva and breast cancer: an emerging approach to guide the delivery of individualised thermal therapy, thermochemotherapy and monitor therapy response. Streckfus CF; Brown RE; Bull JM Int J Hyperthermia; 2010; 26(7):649-61. PubMed ID: 20849260 [TBL] [Abstract][Full Text] [Related]
13. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Calabrò A; Beissbarth T; Kuner R; Stojanov M; Benner A; Asslaber M; Ploner F; Zatloukal K; Samonigg H; Poustka A; Sültmann H Breast Cancer Res Treat; 2009 Jul; 116(1):69-77. PubMed ID: 18592372 [TBL] [Abstract][Full Text] [Related]
14. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Dowsett M; Dunbier AK Clin Cancer Res; 2008 Dec; 14(24):8019-26. PubMed ID: 19088018 [TBL] [Abstract][Full Text] [Related]
15. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme. Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157 [TBL] [Abstract][Full Text] [Related]
16. [Predictive and prognostic markers of breast cancer. Molecular biological analysis of fixed tumor tissue]. Petry C; Gehrmann M; von Törne C; Weber K; Stropp U; Hennig G Pathologe; 2008 Nov; 29 Suppl 2():181-3. PubMed ID: 18843491 [TBL] [Abstract][Full Text] [Related]
17. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM; J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968 [TBL] [Abstract][Full Text] [Related]
18. Impact of basal-like breast carcinoma determination for a more specific therapy. Rakha EA; Reis-Filho JS; Ellis IO Pathobiology; 2008; 75(2):95-103. PubMed ID: 18544964 [TBL] [Abstract][Full Text] [Related]
19. Clinical proteomics in breast cancer: a review. Gast MC; Schellens JH; Beijnen JH Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer. Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]